Related Experiment Video
Updated: Feb 19, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
[Cardiogenic shock is a rare disease: the dedicated network]
Serafina Valente1, Marco Marini2, Ilaria Battistoni3
1S.O.D. Interventistica Cardiologica Strutturale, AOU Careggi, Firenze - Area Emergenza-Urgenza ANMCO.
Insights
Cardiogenic shock (CS) requires rapid diagnosis and aggressive treatment. This review outlines creating a CS network to ensure consistent, high-quality care for all patients, aiming to improve outcomes for this rare condition.
Area of Science:
- Cardiology
- Critical Care Medicine
- Health Systems Management
Background:
- Cardiogenic shock (CS) is a rare but severe condition with persistently high mortality rates.
- Current treatment approaches for CS often involve limited use of circulatory assistance and specialized centers.
- Existing guidelines emphasize early diagnosis, prompt pharmacological support, and intensive care for CS patients.
Purpose of the Study:
- To provide guidelines for establishing a dedicated Cardiogenic Shock (CS) network.
- To identify essential components for creating a CS network within existing health regulations.
- To promote equitable access to optimal care for all CS patients.
Main Methods:
- Review of current epidemiological data and clinical registries on CS.
- Analysis of expert recommendations and consensus documents regarding CS management.
- Development of a framework for a structured CS care network.
Main Results:
- CS necessitates a multidisciplinary, goal-oriented treatment strategy.
- The establishment of specialized CS networks is crucial for improving patient outcomes.
- Standardized protocols and resource allocation are key elements for effective CS care.
Conclusions:
- A coordinated CS network approach is vital for managing this high-mortality condition.
- Implementing a CS network ensures standardized, evidence-based care across different healthcare settings.
- This framework aims to enhance treatment opportunities and outcomes for patients with cardiogenic shock.
Abstract:
Cardiogenic shock (CS) is a rare disease that needs a rapid and multiparameter diagnosis and a timely, aggressive and multidisciplinary goal-oriented treatment. Recently published epidemiological studies and registries underline how SC represents an infrequent clinical entity still burdened by high mortality rates, substantially unchanged over the years. Currently, only few patients with CS are treated with circulatory assistance in dedicated centers. Some consensus documents and expert recommendations emphasize the importance of early diagnosis of CS, immediate pharmacological support, and treatment of precipitating causes, and stress the need for hospitalization in high-volume intensive care centers. The aim of this review is to show the instructions for the creation of a SC network, emphasizing the necessary elements, in agreement with available resources and existing health regulations for giving the same care opportunities to all the patients.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Introduction Cardiac Emergencies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy

